According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...

So far in 2025, the Trump administration has cut more than $1 billion in NIH grants. That includes a study on sickle cell ...

The Centers for Medicare and Medicaid Services has named 33 states, as well as Washington, D.C., and Puerto Rico, as participants in its Cell and Gene Therapy Access Model, which is designed to treat ...

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Sickle cell disease is one of the most common genetic blood disorders in the world. It affects millions globally, with the ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Santa Claus arrived in Montgomery County on Wednesday with a police escort — not because he was in trouble, but because he ...

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...

The more Betsy Adler learned about her family's medical history, the more interested and concerned she became. Several of her first cousins had been treated for cancer, and three of her male ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...